|  | Study period | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Enrolment | Allocation | Post-allocation | Primary and secondary outcomes | ||||||
Time point | -t1 | 0 | 14 days pre-op | 7 days pre- op | Intra-operative | 24-48 h post-op | 7 days post- op | 14 days post- op | 30 days | 90 days |
Enrolment: | ||||||||||
 Eligibility screen (inclusion and exclusion criteria) | X |  |  |  |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |  |  |  |
 Baseline PCS (> 24: eligible to enrol) | X |  |  |  |  |  |  |  |  |  |
 Randomisation |  | X |  |  |  |  |  |  |  |  |
Interventions: | ||||||||||
 CBT session group |  |  | X | X |  |  | X | X |  |  |
 PEM session group |  |  | X | X |  |  | X | X |  |  |
Assessments: | ||||||||||
 Patient demographics and characteristics | X |  |  |  |  |  |  |  |  |  |
 Intraoperative data |  |  |  |  | X |  |  |  |  |  |
 BPI |  | X |  |  |  |  |  |  | X | X |
 QoR-15 |  |  |  |  |  | X |  |  |  |  |
 PCS | x |  |  |  |  |  |  |  | X | X |
 HADS |  |  |  |  |  |  |  |  | X | X |